Criteria for waiver of informed consent for quality improvement research-reply

Affiliations

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco2Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.
² The Greenwall Foundation, New York, New York.
³ Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco5Deputy Editor, JAMA Internal Medicine.

Comment

Mark J Pletcher et al. JAMA Intern Med. 2015 Jan.

. 2015 Jan;175(1):143.

doi: 10.1001/jamainternmed.2014.6997.

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco2Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.
² The Greenwall Foundation, New York, New York.
³ Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco5Deputy Editor, JAMA Internal Medicine.

No abstract available

Comment on

Informed consent in randomized quality improvement trials: a critical barrier for learning health systems.
Pletcher MJ, Lo B, Grady D. Pletcher MJ, et al. JAMA Intern Med. 2014 May;174(5):668-70. doi: 10.1001/jamainternmed.2013.13297. JAMA Intern Med. 2014. PMID: 24615554 No abstract available.
Criteria for waiver of informed consent for quality improvement research.
Baker DW, Persell SD. Baker DW, et al. JAMA Intern Med. 2015 Jan;175(1):142-3. doi: 10.1001/jamainternmed.2014.6977. JAMA Intern Med. 2015. PMID: 25560946 No abstract available.